After further studying whether metformin could improve endometrial insulin resistance, they found that the expression of SLC2A4 mRNA and protein in obese PCOS patients was significantly lower than that in obese non-PCOS patients (61). The gene discussed is SLC2A4; the disease is polycystic ovary syndrome.